Recombinant Breast Carcinoma Amplified Sequence 3 (BCAS3)

GAOB1; MAAB; GAOB1

  • Recombinant Breast Carcinoma Amplified Sequence 3 (BCAS3) Packages (Simulation)
  • Recombinant Breast Carcinoma Amplified Sequence 3 (BCAS3) Packages (Simulation)
  • RPF221Hu01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE of the Recombinant Breast Carcinoma Amplified Sequence 3 (BCAS3)

USAGE of the Recombinant Breast Carcinoma Amplified Sequence 3 (BCAS3)

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE of the Recombinant Breast Carcinoma Amplified Sequence 3 (BCAS3)

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY of the Recombinant Breast Carcinoma Amplified Sequence 3 (BCAS3)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
RPF221Hu01 Recombinant Breast Carcinoma Amplified Sequence 3 (BCAS3) Positive Control; Immunogen; SDS-PAGE; WB.
PAF221Hu01 Polyclonal Antibody to Breast Carcinoma Amplified Sequence 3 (BCAS3) WB; IHC; ICC; IP.
GUESTBOOK